Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Hepatology

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.20323PMID 15368453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increases in clinically severe obesity in the United States, 1986-2000.

  2003cited by this paper
• Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

  2003cited by this paper
• 158 Histologic correlation of paired right lobe and left lobe liver biopsies in morbidly obese individuals with suspected non alcoholic fatty liver disease

  2003cited by this paper
• 160 Design and validation of a histologic scoring system for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

  2003cited by this paper
• Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

  2003cited by this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• AGA technical review on nonalcoholic fatty liver disease.

  2002cited by this paper
• Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

  2002cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Obese children with steatohepatitis can develop cirrhosis in childhood

  2002cited by this paper
• Pro-inflammatory cytokines and adipose tissue

  2001cited by this paper
• Current status of medical and surgical therapy for obesity.

  2001cited by this paper
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.

  2001cited by this paper
• Laparoscopic surgery for morbid obesity.

  2001cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• Adipocyte Differentiation: From Fibroblast to Endocrine Cell

  2001cited by this paper
• Fat Cell Function and Fibrinolysis

  2000cited by this paper
• Liver fibrosis in overweight patients.

  2000cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

  1999cited by this paper
• New classification and criteria for diagnosis of diabetes mellitus

  1999cited by this paper
• Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

  1999cited by this paper
• Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

  1998cited by this paper
• Hepatic steatosis: Innocent bystander or guilty party?

  1998cited by this paper
• Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty

  1998cited by this paper
• Gastrointestinal surgery for severe obesity. NIH consensus development conference, March 25-7,1991.

  1996cited by this paper
• The role of laparoscopy in the diagnosis of cirrhosis.

  1996cited by this paper
• L-arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and airways.

  1993cited by this paper
• Gastrointestinal Surgery for Severe Obesity.

  1991cited by this paper
• Liver pathology in morbidly obese patients with and without diabetes.

  1990cited by this paper
• Lipid peroxidation, iron mobilization and radical generation induced by alcohol.

  1989cited by this paper
• Liver in obesity.

  1985cited by this paper
• Liver morphology in morbid obesity: a literature study.

  1984cited by this paper
• Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen.

  1983cited by this paper
• Sampling variability on percutaneous liver biopsy.

  1979cited by this paper
• Fatty liver hepatitis and cirrhosis in obese patients.

  1979cited by this paper
• Jejunoileal bypass in the treatment of morbid obesity.

  1978cited by this paper
• Jejunoileal bypass as a treatment of morbid obesity.

  1977cited by this paper
• Fatty metamorphosis of the liver in morbid obesity.

  1973cited by this paper
• The liver in obesity.

  1952cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Liver Pathology and the Metabolic Syndrome X in

  year unknowncited by this paper

• Total Flavonoids of Engelhardia roxburghiana Wall. Attenuated Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inflammation Through Targeting SREBP1 and PPARα

  2025cites this paper
• The obesity pandemic and its impact on non-communicable disease burden

  2025cites this paper
• Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis

  2024cites this paper
• Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,496 adults using serial echocardiography.

  2024cites this paper
• Development, Validation, and Application of a Scoring Model for Non-alcoholic Steatohepatitis

  2023cites this paper
• Correlation between Body Mass Index and Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Inflammation in obesity, diabetes, and related disorders.

  2022cites this paper
• The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease

  2022cites this paper
• Adherence to low carbohydrate diets and non-alcoholic fatty liver disease: a case control study

  2022cites this paper
• Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report

  2021influential citation
• Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease

  2021cites this paper
• Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgery.

  2021cites this paper
• Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions.

  2021cites this paper
• Steatosis, Steatohepatitis and Related Conditions

  2021cites this paper
• The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD

  2021cites this paper
• Porphyran‐derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice

  2021cites this paper
• The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.

  2021cites this paper
• Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical Practice.

  2021cites this paper
• Does vitamin D replacement therapy cause a regression in fatty liver disease? A case control study of comparison of vitamin D and other common therapy modalities

  2021cites this paper
• Adherence to Ideal Cardiovascular Health Metrics Is Associated With Reduced Odds of Hepatic Steatosis

  2020cites this paper
• Histopathology of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Evaluation of NAFLD and fibrosis in obese patients – a comparison of histological and clinical scoring systems

  2020cites this paper
• LABS Project

  2019cites this paper
• Clinical and pathophysiological aspects of nonalcoholic fatty liver disease in bariatric surgery

  2019cites this paper
• Histologic findings of advanced fibrosis and cirrhosis in patients with NAFLD who have normal aminotransferase levels

  2019cites this paper
• Liver-related complications and metabolic comorbidities during long-term follow-up of patients with Non-Alcoholic Fatty Liver Disease

  2019cites this paper
• Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.

  2019cites this paper
• Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease

  2019cites this paper
• Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern

  2019cites this paper
• Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States

  2019cites this paper
• Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

  2019cites this paper
• Fighting liver fat

  2019cites this paper
• EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS.

  2019cites this paper
• Prevalence, patterns and predictive factors of non-alcoholic fatty liver disease among morbidly obese patients undergoing sleeve gastrectomy

  2018cites this paper
• Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis C Viral Infection

  2018cites this paper
• Identification et stratification du risque cardiométabolique lié à l'obésité ou au diabète de type 2 chez les femmes en surpoids ou obèse post-ménopausées : exploration d’indicateurs biologiques & morphologiques

  2018cites this paper
• Adult Non-alcoholic Fatty Liver Disease (NAFLD)

  2018cites this paper
• Clinical relevance of liver histopathology and different histological classifications of NASH in adults

  2018cites this paper
• Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.

  2018cites this paper
• Systematic review and meta‐analysis: non‐invasive detection of non‐alcoholic fatty liver disease related fibrosis in the obese

  2018cites this paper
• Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives.

  2017cites this paper
• Induction of proliferation and activation of rat hepatic stellate cells via high glucose and high insulin.

  2017cites this paper
• Genomic studies in non-alcoholic fatty liver disease

  2017cites this paper
• Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease

  2017cites this paper
• PROTOCOLS FOR PERIOPERATIVE NUTRITIONAL CARE PRACTICE IN ACCREDITED BARIATRIC SURGICAL CENTERS: A SURVEY OF CURRENT PRACTICE

  2017influential citation
• Dietary salecan reverts partially the metabolic gene expressions and NMR-based metabolomic profiles from high-fat-diet-induced obese rats.

  2017cites this paper
• NAFLD and diabetes mellitus

  2017cites this paper
• Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.

  2017cites this paper
• Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review

  2017cites this paper
• Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations

  2016cites this paper
• Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery

  2016cites this paper
• Evaluation of L-Carnitine Efficacy in the Treatment of Non-Alcoholic Fatty Liver Disease among Diabetic Patients: A Randomized Double Blind Pilot Study

  2016cites this paper
• Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study

  2016cites this paper
• Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese

  2016cites this paper
• Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy

  2016cites this paper
• Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome

  2016cites this paper
• Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease

  2016cites this paper
• Epidemiology and natural history of non-alcoholic fatty liver disease.

  2016cites this paper
• Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges

  2015cites this paper
• Estudio de la variación a largo plazo de los parámetros bioquímicos metabólicos en pacientes con obesidad mórbida e intervenidos mediante bypass gástrico laparoscópico

  2015cites this paper
• Endocrine causes of nonalcoholic fatty liver disease.

  2015cites this paper
• Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea

  2015cites this paper
• Prevalence of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Sleeve Bariatric Surgery in Iran and Association With Other Comorbid Conditions

  2015cites this paper
• Effect of Roux-en-y Gastric Bypass on Nonalcoholic Fatty Liver Disease Evaluated Through NAFLD Fibrosis Score: a Prospective Study

  2015cites this paper
• The role of liver biopsy to assess non-alcoholic fatty liver disease.

  2015cites this paper
• High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.

  2015influential citation
• Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients

  2015cites this paper
• Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery

  2015cites this paper
• Revisión Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents ?

  2015cites this paper
• A population-based study on the prevalence of NASH using scores validated against liver histology.

  2014cites this paper
• Fatty liver disease

  2014cites this paper
• Nonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound Evaluation

  2014cites this paper
• Steatosis and Steatohepatitis: Complex Disorders

  2014cites this paper
• Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity

  2014cites this paper
• A lipoperoxidação plasmática como preditor de esteatohepatite não alcoólica em obesos mórbidos com doença hepática gordurosa não alcoólica

  2014cites this paper
• The Liver in Metabolic Syndrome

  2014cites this paper
• Markers in nonalcoholic steatohepatitis.

  2013cites this paper
• Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.

  2013cites this paper
• The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes

  2013cites this paper
• Assessment of liver biopsies in obese patients: a histological and immunohistochemical study

  2013cites this paper
• Susceptibility and Gene Interaction Study of the Angiotensin II Type 1 Receptor (AGTR1) Gene Polymorphisms with Non-Alcoholic Fatty Liver Disease in a Multi-Ethnic Population

  2013cites this paper
• The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors.

  2013cites this paper
• The Safety and Efficacy of Bariatric Surgery: The Longitudinal Assessment of Bariatric Surgery (LABS)

  2013cites this paper
• Assessment of Hepatotoxicity of Obesity in Female Patients' through Histopathological, Biochemical and Immunohistochemical Study

  2013cites this paper
• Reg ional me tabolic liv er func tion measur ed in pat ients with cirrhosis by 2-( 18 F)fluoro-2-deo xy- D-ga lactose PET/ CT

  2013cites this paper
• Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients

  2013cites this paper
• The role of ARNT in liver and myeloid cell function

  2013cites this paper
• Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

  2012cites this paper
• The epidemiology, pathogenesis and histopathology of fatty liver disease

  2012cites this paper
• Steatosis in non alcoholic fatty liver disease

  2012cites this paper
• The increased prevalence of non‐alcoholic fatty liver disease in psoriatic patients: A study from South India

  2012cites this paper
• Nonalcoholic Fatty Liver Disease: What the Pathologist Can Tell the Clinician

  2012cites this paper
• Nonalcoholic Fatty Liver Disease: A Pathological View

  2012cites this paper
• Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research

  2012cites this paper
• The Impact of Bariatric Surgery on Nonalcoholic Steatohepatitis

  2012cites this paper
• Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.

  2012influential citation
• Is nonalcoholic fatty liver disease in children the same disease as in adults?

  2012cites this paper
• Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?

  2012cites this paper
• Cognitive‐Behavioral Treatment of Nonalcoholic Fatty Liver Disease: A Propensity Score‐Adjusted Observational Study

  2011cites this paper
• Obesity and Fatty Liver Are ‘Grease’ for the Machinery of Hepatic Fibrosis

  2011cites this paper